Year archive

PYC THERAPEUTICS LIMITED — 2025 filings

All 74 regulatory filings released by PYC THERAPEUTICS LIMITED (PYC) in 2025, sourced directly from the official regulator.

74 Filings

2025 Period

2025 filings (74)

Filing	Released	Lang
Issue of Director Options 6 pages 406.2KB Regulatory Filings	2025-12-22	English
Notification regarding unquoted securities - PYC 7 pages 21.7KB Regulatory Filings	2025-12-22	English
Change of Director's Interest Notice - Peter Coleman 2 pages 281.6KB Regulatory Filings	2025-12-22	English
PKD Clinical Trial - Safety Outcomes in Part A 4 pages 303.4KB Regulatory Filings	2025-12-18	English
Change of Director's Interest Notice 2 pages 278.7KB Regulatory Filings	2025-11-25	English
PKD Clinical Trial - Approval to Escalate Dosing 4 pages 283.5KB Regulatory Filings	2025-11-23	English
Annual General Meeting Presentation 10 pages 1.1MB Regulatory Filings	2025-11-17	English
Becoming a substantial holder 3 pages 311.0KB Regulatory Filings	2025-11-17	English
Results of Annual General Meeting 2 pages 222.0KB Regulatory Filings	2025-11-17	English
Appendix 3X and 3Z 5 pages 485.5KB Regulatory Filings	2025-11-17	English
Sustained Vision Improvement in RP11 Patients 4 pages 325.9KB Regulatory Filings	2025-11-13	English
Board Renewal 3 pages 218.4KB Regulatory Filings	2025-11-12	English
Annual General Meeting - Conference Link 1 page 175 Regulatory Filings	2025-11-10	English
Becoming a substantial holder 7 pages 464.8KB Regulatory Filings	2025-11-06	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 594.9KB Regulatory Filings	2025-10-26	English
ADOA Program Initiation of Global Repeat Dose Study 4 pages 314.6KB Regulatory Filings	2025-10-20	English
Notice of Annual General Meeting/Proxy Form 17 pages 739.7KB Regulatory Filings	2025-10-16	English
Investor Webinar Presentation 6 pages 426.5KB Regulatory Filings	2025-10-12	English
PMS Program Data Supports Progression to Human Trials 7 pages 1.7MB Regulatory Filings	2025-10-12	English
ADOA Program Progressing to Multiple Dose Study 3 pages 230.0KB Regulatory Filings	2025-10-08	English
Investor Webinar 2 pages 190.9KB Regulatory Filings	2025-09-29	English
Board and Management Changes 4 pages 242.2KB Regulatory Filings	2025-09-21	English
Appendix 3X and 3Z 11 pages 625.3KB Regulatory Filings	2025-09-21	English
Trading Halt 2 pages 302.6KB Regulatory Filings	2025-09-18	English
Correction to Trading Halt Request 1 page 167.4KB Regulatory Filings	2025-09-18	English
Change of Managing Director 3 pages 209.4KB Regulatory Filings	2025-09-16	English
ADOA Program - Presentation of Clinical Data at NOSA 2025 3 pages 1.1MB Regulatory Filings	2025-09-04	English
PKD Program - Presentation of Safety Data at ANZSN 16 pages 1.8MB Regulatory Filings	2025-08-28	English
Appendix 4E 3 pages 312.4KB Regulatory Filings	2025-08-27	English
2025 Annual Report to Shareholders 94 pages 3.2MB Regulatory Filings	2025-08-27	English
Appendix 4G 12 pages 382.6KB Regulatory Filings	2025-08-27	English
2025 Corporate Governance Statement 25 pages 522.1KB Regulatory Filings	2025-08-27	English
Approval to Escalate Dosing in Kidney Disease Clinical Trial 4 pages 315.9KB Regulatory Filings	2025-08-07	English
Q3 2025 Investor Webinar Presentation 25 pages 1.7MB Regulatory Filings	2025-07-31	English
Q3 Investor Webinar 1 August 2025 2 pages 270.3KB Regulatory Filings	2025-07-27	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 690.8KB Regulatory Filings	2025-07-20	English
Approval to Progress Kidney Disease Trial to Next Stage 4 pages 364.4KB Regulatory Filings	2025-07-06	English
Fourth Drug Program Progressing to Human Trials 22 pages 3.0MB Regulatory Filings	2025-06-26	English
FDA Alignment on Registrational Trial Design RP11 Program 3 pages 288.0KB Regulatory Filings	2025-06-22	English
SRC Approves Dose Escalation in ADOA Clinical Trial 5 pages 403.0KB Regulatory Filings	2025-06-10	English
Investor Webinar Presentation 13 pages 814.5KB Regulatory Filings	2025-05-29	English
Approval to Escalate Dosing in Kidney Disease Trial 4 pages 531.2KB Regulatory Filings	2025-05-25	English
Notification of cessation of securities - PYC 5 pages 17.2KB Regulatory Filings	2025-05-22	English
Q2 Investor Webinar 30 May 2025 2 pages 251.9KB Regulatory Filings	2025-05-12	English
Foundation Fighting Blindness Presentation Materials 25 pages 2.3MB Regulatory Filings	2025-05-01	English
Presentation of Clinical Proof of Concept in Lead Program 9 pages 898.2KB Regulatory Filings	2025-04-27	English
Change in substantial holding 3 pages 259.3KB Regulatory Filings	2025-04-27	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 547.4KB Regulatory Filings	2025-04-23	English
Application for quotation of securities - PYC 5 pages 16.5KB Regulatory Filings	2025-04-22	English
Completion of Entitlement Offer 2 pages 231.0KB Regulatory Filings	2025-04-16	English
First Subject Dosed in PKD Clinical Trial 4 pages 463.0KB Regulatory Filings	2025-04-09	English
Placement of Shortfall 2 pages 228.2KB Regulatory Filings	2025-04-08	English
Investor Webinar Presentation 21 pages 794.1KB Regulatory Filings	2025-03-27	English
Q1 Investor Webinar 28 March 2025 2 pages 261.2KB Regulatory Filings	2025-03-20	English
Application for quotation of securities - PYC 6 pages 18.4KB Regulatory Filings	2025-03-20	English
Completion of Retail Entitlement Offer 2 pages 251.6KB Regulatory Filings	2025-03-17	English
Half Yearly Report and Accounts 23 pages 1.5MB Regulatory Filings	2025-02-26	English
Ceasing to be a substantial holder 2 pages 198.2KB Regulatory Filings	2025-02-26	English
Change of Director's Interest Notice 2 pages 276.1KB Regulatory Filings	2025-02-26	English
Application for quotation of securities - PYC 5 pages 16.7KB Regulatory Filings	2025-02-25	English
Retail Entitlement Offer Booklet 82 pages 2.2MB Regulatory Filings	2025-02-23	English
Despatch of Retail Offer Document 2 pages 209.3KB Regulatory Filings	2025-02-23	English
Despatch of Notice to Ineligible Retail Shareholders 5 pages 479.5KB Regulatory Filings	2025-02-23	English
Completion of Institutional Entitlement Offer 3 pages 270.1KB Regulatory Filings	2025-02-18	English
Trading Halt 3 pages 276.5KB Regulatory Filings	2025-02-16	English
PYC Equity Raising to Raise up to $146 Million 7 pages 305.4KB Regulatory Filings	2025-02-16	English
PYC Equity Raising Presentation 36 pages 1.1MB Regulatory Filings	2025-02-16	English
Proposed issue of securities - PYC 7 pages 25.3KB Regulatory Filings	2025-02-16	English
Cleansing Notice Under Section 708AA 5 pages 239.9KB Regulatory Filings	2025-02-16	English
Approval to Commence Human Trials in Kidney Program 5 pages 350.5KB Regulatory Filings	2025-02-09	English
Notification of cessation of securities - PYC 4 pages 15.4KB Regulatory Filings	2025-02-02	English
ADOA Safety Review Committee Approves Dose Escalation 4 pages 278.1KB Regulatory Filings	2025-01-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 674.0KB Regulatory Filings	2025-01-28	English
US FDA Grants Rare Pediatric Disease Designation to VP-001 3 pages 248.4KB Regulatory Filings	2025-01-19	English

Filings by year

2026 46 filings
2025 74 filings
2024 90 filings
2023 72 filings
2022 37 filings
2021 60 filings
2020 76 filings
2019 63 filings
2018 56 filings
2017 74 filings
2016 45 filings
2015 55 filings
2014 41 filings
2013 49 filings
2012 49 filings
2011 65 filings
2010 68 filings
2009 58 filings
2008 41 filings
2007 54 filings
2006 69 filings
2005 54 filings